Jarkvist Jesper, Gülen Theo
Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden.
Department of Medicine Solna, Division of Immunology and Allergy, Karolinska Institutet, 171 77 Stockholm, Sweden.
Diagnostics (Basel). 2023 Jun 30;13(13):2241. doi: 10.3390/diagnostics13132241.
Anaphylactic reactions are a well-known feature of mastocytosis, particularly in relation to hymenoptera venom stings. Although data on the frequency of drug hypersensitivity reactions is limited in mastocytosis, it is hypothesized that these patients may be predisposed to hypersensitivity reactions to certain drugs, including antibiotics. Nevertheless, this issue has not been systematically investigated. Thus, we investigate the prevalence and clinical features of hypersensitivity reactions to antibiotics (HRA) in mastocytosis.
A 15-year retrospective study was conducted among 239 (≥18 years old) consecutive mastocytosis patients who were investigated in our center. All patients underwent a thorough allergy work-up, where self-reported reactions were individually evaluated by an allergist.
Overall, 34 patients (14.2%) were deemed to have HRA. Most patients reacted with cutaneous symptoms (74%), and anaphylaxis was rare, confirmed only in two of 34 patients (0.8%). Beta-lactams were the most common elicitors (63%). There were no differences in age, gender, atopic status and tryptase levels between mastocytosis patients with and without antibiotic hypersensitivity.
The present study indicates a similar prevalence of HRA in mastocytosis compared to those of the general population. Moreover, antibiotics appear to be rare elicitors of anaphylaxis in these patients. Hence, our results suggest that mastocytosis patients without a history of HRA may be treated with these drugs without special precautions.
过敏反应是肥大细胞增多症的一个众所周知的特征,尤其是与膜翅目昆虫毒液叮咬有关。尽管关于肥大细胞增多症中药物过敏反应频率的数据有限,但据推测这些患者可能易对某些药物产生过敏反应,包括抗生素。然而,这个问题尚未得到系统研究。因此,我们调查了肥大细胞增多症患者对抗生素过敏反应(HRA)的患病率和临床特征。
对在我们中心接受调查的239名(≥18岁)连续的肥大细胞增多症患者进行了一项为期15年的回顾性研究。所有患者都接受了全面的过敏检查,由过敏症专科医生对自我报告的反应进行单独评估。
总体而言,34名患者(14.2%)被认为患有HRA。大多数患者表现为皮肤症状(74%),过敏反应很少见,34名患者中仅2名得到确诊(0.8%)。β-内酰胺类是最常见的诱发因素(63%)。有抗生素过敏和无抗生素过敏的肥大细胞增多症患者在年龄、性别、特应性状态和类胰蛋白酶水平方面没有差异。
本研究表明,肥大细胞增多症患者中HRA的患病率与普通人群相似。此外,抗生素似乎是这些患者过敏反应的罕见诱发因素。因此,我们的结果表明,无HRA病史的肥大细胞增多症患者在使用这些药物时可能无需采取特殊预防措施。